ADREVIEW
Google image searchProduct monograph
Active ingredient
iobenguane 123 i, 74 MBq/ML
DIN: 02387034
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: GE HEALTHCARE CANADA INC
Date: 26-FEB-2019
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX01 — IOBENGUANE (123 I) (ATC/DDD)
